GE HealthCare Technologies (GEHC) Stock Forecast & Price Target

$69.85 -1.47 (-2.06%)

Closing price 08/1/2025 04:00 PM Eastern

Extended Trading

$70.10 +0.25 (+0.36%)

As of 08/1/2025 07:54 PM Eastern

GE HealthCare Technologies - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 11 Analyst Ratings

Sell
0

Hold
3

Buy
8

Based on 11 Wall Street analysts who have issued ratings for GE HealthCare Technologies in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 11 analysts, 3 have given a hold rating, and 8 have given a buy rating for GEHC.

Consensus Price Target

$88.55
26.77% Upside

According to the 11 analysts' twelve-month price targets for GE HealthCare Technologies, the average price target is $88.55. The highest price target for GEHC is $103.00, while the lowest price target for GEHC is $73.00. The average price target represents a forecasted upside of 26.77% from the current price of $69.85.

Get the Latest News and Ratings for GEHC and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for GE HealthCare Technologies and its competitors.

GEHC Analyst Ratings Over Time

Type	Current Forecast 8/2/24 to 8/2/25	1 Month Ago 7/3/24 to 7/3/25	3 Months Ago 5/4/24 to 5/4/25	1 Year Ago 8/3/23 to 8/2/24
Strong Buy	0 Strong Buy rating(s)	1 Strong Buy rating(s)	1 Strong Buy rating(s)	1 Strong Buy rating(s)
Buy	8 Buy rating(s)	8 Buy rating(s)	8 Buy rating(s)	6 Buy rating(s)
Hold	3 Hold rating(s)	3 Hold rating(s)	1 Hold rating(s)	5 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$88.55	$88.27	$89.40	$94.09
Forecasted Upside	26.77% Upside	15.93% Upside	26.75% Upside	12.76% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

GEHC Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

GEHC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

GE HealthCare Technologies Stock vs. The Competition

Type	GE HealthCare Technologies	Medical Companies	S&P 500
Consensus Rating Score	2.73	2.81	2.53
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	26.77% Upside	10,407.36% Upside	14.55% Upside
News Sentiment Rating	Positive News See Recent GEHC News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
7/31/2025	Citigroup 3 of 5 stars	Joanne Wuensch Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Buy ➝ Buy	$89.00 ➝ $93.00	+30.40%
7/31/2025	Morgan Stanley 3 of 5 stars	Patrick Wood Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Equal Weight ➝ Equal Weight	$78.00 ➝ $74.00	+3.21%
7/14/2025	BTIG Research 2 of 5 stars		Reiterated Rating	Buy ➝ Buy
5/5/2025	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Graham Doyle Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Sell ➝ Neutral	$74.00 ➝ $73.00	+3.50%
5/1/2025	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. Roman Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Buy ➝ Buy	$94.00 ➝ $82.00	+19.42%
5/1/2025	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Larry Biegelsen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Overweight ➝ Overweight	$103.00 ➝ $89.00	+29.06%
5/1/2025	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Vijay Kumar Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Outperform ➝ Outperform	$96.00 ➝ $85.00	+22.20%
4/23/2025	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Overweight ➝ Overweight	$104.00 ➝ $88.00	+35.41%
1/8/2025	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Hold ➝ Buy	$95.00 ➝ $103.00	+23.55%
9/30/2024	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$100.00 ➝ $102.00	+10.88%
Get the Latest News and Ratings for GEHC and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for GE HealthCare Technologies and its competitors with MarketBeat's FREE daily newsletter.
9/9/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Neutral	$90.00	+5.77%
8/1/2024	Redburn Atlantic Subscribe to MarketBeat All Access for the recommendation accuracy rating	E. Ridley-Day Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
5/1/2024	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Neutral ➝ Neutral	$94.00 ➝ $86.00	+10.45%
5/1/2024	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$110.00 ➝ $105.00	+35.45%
4/1/2024	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$80.00 ➝ $110.00	+22.82%
2/15/2024	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$100.00	+20.24%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 12:51 PM ET.

Should I Buy GE HealthCare Technologies Stock? GEHC Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Thursday, July 31, 2025. Please send any questions or comments about these GE HealthCare Technologies pros and cons to contact@marketbeat.com.

GE HealthCare Technologies
Bull Case

Here are some ways that investors could benefit from investing in GE HealthCare Technologies Inc.:

The company recently reported strong earnings, with earnings per share (EPS) of $1.06, surpassing expectations, indicating robust financial health and operational efficiency.
GE HealthCare Technologies Inc. has announced a significant share buyback plan of $1.00 billion, which suggests that the leadership believes the stock is undervalued, potentially enhancing shareholder value.
The current stock price is around $89, reflecting a solid market position and investor confidence in the company's growth prospects.
With a return on equity of 24.95%, the company demonstrates effective management and profitability, which can attract more investors looking for strong returns.
The firm has shown consistent revenue growth, with a year-over-year increase of 3.5%, indicating a positive trend in its business operations and market demand.

GE HealthCare Technologies
Bear Case

Investors should be bearish about investing in GE HealthCare Technologies Inc. for these reasons:

The stock has experienced fluctuations, with a one-year high of $94.80 and a low of $57.65, indicating potential volatility that could deter risk-averse investors.
Despite recent growth, the company has a relatively low dividend yield of 0.18%, which may not be attractive for income-focused investors.
The price-to-earnings (P/E) ratio of 15.09 suggests that the stock may be fairly valued, limiting potential upside for investors seeking high-growth opportunities.
Analysts have mixed ratings on the stock, with some downgrading price targets, which could signal uncertainty about future performance.
The company has a debt-to-equity ratio of 0.73, which, while manageable, indicates that it relies on debt financing, potentially increasing financial risk in adverse market conditions.

GEHC Forecast - Frequently Asked Questions

: According to the research reports of 11 Wall Street equities research analysts, the average twelve-month stock price forecast for GE HealthCare Technologies is $88.55, with a high forecast of $103.00 and a low forecast of $73.00.
: 11 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for GE HealthCare Technologies in the last year. There are currently 3 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" GEHC shares.
: According to analysts, GE HealthCare Technologies's stock has a predicted upside of 26.77% based on their 12-month stock forecasts.
: Over the previous 90 days, GE HealthCare Technologies's stock had 1 upgrade by analysts.
: GE HealthCare Technologies has been rated by research analysts at BTIG Research, Citigroup, Morgan Stanley, and UBS Group in the past 90 days.
: Analysts like GE HealthCare Technologies less than other "medical" companies. The consensus rating score for GE HealthCare Technologies is 2.73 while the average consensus rating score for "medical" companies is 2.81. Learn more on how GEHC compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top-Rated Stocks

More Ratings Tools

This page (NASDAQ:GEHC) was last updated on 8/2/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

GE HealthCare Technologies (GEHC) Stock Forecast & Price Target